« Return to News | Study Conduct

Pacific Urology, Diablo Valley Oncology merge launching multi-specialty practice

Monday, November 14, 2011 10:07 AM

Two private specialty medical practices have agreed to merge forming the area's first multi-specialty practice in oncology and urology as a hedge against mounting business challenges in a rapidly changing healthcare landscape.

Pacific Urology is joining forces with Diablo Valley Oncology and Hematology Medical Group into a 13-physician group. The practices gave two principal motivations: stronger continuity of care, plus increasing economic pressures, such as a 30%  decrease in Medicare payments anticipated in 2012.

Both practices will retain their individual names but will now share infrastructure and resources such as information technology, business office processes and clinic locations.

"In the end, it's win-win for us and patients," said Dr. Matthew Sirott,
CEO of Diablo Valley Oncology. "Now we'll jointly be able to see more
patients in more locations, reduce overhead expenses, and collaborate more
closely than ever."

With clinics in Concord, Walnut Creek, Antioch, Brentwood, San Ramon, and Livermore, Pacific Urology is one of the San Francisco Bay Area's largest
urology practices. The group's mission is to provide university quality of
care in a private practice setting, right in the patients' community.

Diablo Valley Oncology and Hematology Medical Group is home to the largest
single site for cancer treatment in California's Contra Costa County. Its seven
physicians bring together medical oncology; hematology; chemotherapy; radiation therapy; CT/MRI/PET-CT scans and imaging; clinical trials; research; and supportive care all in one location.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.